{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T15:13:39Z","timestamp":1761664419608,"version":"build-2065373602"},"reference-count":20,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Reumatolog\u00eda Cl\u00ednica"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.reuma.2020.07.001","type":"journal-article","created":{"date-parts":[[2020,7,25]],"date-time":"2020-07-25T02:07:50Z","timestamp":1595642870000},"page":"311-312","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"P1","title":["The Cardio-Rheumatology Approach to Atherosclerotic Cardiovascular Disease"],"prefix":"10.1016","volume":"16","author":[{"given":"Ricardo O.","family":"Esc\u00e1rcega","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Garc\u00eda-Carrasco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Mendoza-Pinto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.reuma.2020.07.001_bib0105","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1161\/CIR.0000000000000659","article-title":"Heart disease and stroke statistics-2019 update: a report from the American Heart Association","volume":"139","author":"Benjamin","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/j.reuma.2020.07.001_bib0110","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1097\/BOR.0000000000000528","article-title":"Cardiovascular disease in systemic lupus erythematosus: an update","volume":"30","author":"Liu","year":"2018","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.reuma.2020.07.001_bib0115","series-title":"Accelerated atherosclerosis in systemic lupus erythematosus: perspectives towards decreasing cardiovascular morbidity and mortality. Vol. 18, Lupus. England","first-page":"383","author":"Esc\u00e1rcega","year":"2009"},{"key":"10.1016\/j.reuma.2020.07.001_bib0120","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/nrcardio.2017.34","article-title":"Effects of dyslipidaemia on monocyte production and function in cardiovascular disease","volume":"14","author":"Rahman","year":"2017","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.reuma.2020.07.001_bib0125","doi-asserted-by":"crossref","first-page":"3883","DOI":"10.1073\/pnas.81.12.3883","article-title":"Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids","volume":"81","author":"Steinbrecher","year":"1984","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.reuma.2020.07.001_bib0130","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/978-1-60327-029-8_24","article-title":"Oxidized low-density lipoprotein","volume":"610","author":"Parthasarathy","year":"2010","journal-title":"Methods Mol Biol"},{"key":"10.1016\/j.reuma.2020.07.001_bib0135","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1093\/eurheartj\/ehu203","article-title":"Anti-inflammatory therapies for cardiovascular disease","volume":"35","author":"Ridker","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/j.reuma.2020.07.001_bib0140","doi-asserted-by":"crossref","first-page":"e11765","DOI":"10.1371\/journal.pone.0011765","article-title":"Cholesterol crystals activate the NLRP3 inflammasome in human macrophages: a novel link between cholesterol metabolism and inflammation","volume":"5","author":"Rajam\u00e4ki","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.reuma.2020.07.001_bib0145","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.amjmed.2018.04.027","article-title":"A reappraisal of the lipid hypothesis","volume":"131","author":"DuBroff","year":"2018","journal-title":"Am J Med U S"},{"key":"10.1016\/j.reuma.2020.07.001_bib0150","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMoa1615664","article-title":"Evolocumab and clinical outcomes in patients with cardiovascular disease","volume":"376","author":"Sabatine","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.reuma.2020.07.001_bib0155","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.reuma.2020.07.001_bib0160","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.autrev.2006.07.001","article-title":"Insulin resistance, chronic inflammatory state and the link with systemic lupus erythematosus-related coronary disease","volume":"6","author":"Esc\u00e1rcega","year":"2006","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.reuma.2020.07.001_bib0165","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1093\/oxfordjournals.aje.a009122","article-title":"Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham Study","volume":"145","author":"Manzi","year":"1997","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.reuma.2020.07.001_bib0170","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/00005792-199905000-00003","article-title":"Morbidity and mortality in systemic lupus erythematosus during a 5-year period. A multicenter prospective study of 1,000 patients. European Working Party on Systemic Lupus Erythematosus","volume":"78","author":"Cervera","year":"1999","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.reuma.2020.07.001_bib0175","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1177\/0961203307076519","article-title":"Lack of subclinical myocardial ischaemia in Mexican patients with systemic lupus erythematosus without traditional risk factors for coronary artery disease","volume":"16","author":"Garc\u00eda-Carrasco","year":"2007","journal-title":"Lupus"},{"key":"10.1016\/j.reuma.2020.07.001_bib0180","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/S0140-6736(09)60503-1","article-title":"Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials","volume":"373","author":"Baigent","year":"2009","journal-title":"Lancet (London, England)"},{"key":"10.1016\/j.reuma.2020.07.001_bib0185","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1007\/s12026-013-8409-8","article-title":"Statins and autoimmunity","volume":"56","author":"Khattri","year":"2013","journal-title":"Immunol Res"},{"key":"10.1016\/j.reuma.2020.07.001_bib0190","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.1161\/CIRCULATIONAHA.106.178458","volume":"114","author":"Budoff","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/j.reuma.2020.07.001_bib0195","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","article-title":"2019 ESC\/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk","volume":"41","author":"Mach","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.reuma.2020.07.001_bib0200","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2018.01.021","article-title":"Inflammation and atherosclerosis: cardiovascular evaluation in patients with autoimmune diseases","volume":"17","author":"Esc\u00e1rcega","year":"2018","journal-title":"Autoimmun Rev"}],"container-title":["Reumatolog\u00eda Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1699258X2030156X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1699258X2030156X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T14:59:56Z","timestamp":1761663596000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1699258X2030156X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":20,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["S1699258X2030156X"],"URL":"https:\/\/doi.org\/10.1016\/j.reuma.2020.07.001","relation":{},"ISSN":["1699-258X"],"issn-type":[{"type":"print","value":"1699-258X"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Cardio-Rheumatology Approach to Atherosclerotic Cardiovascular Disease","name":"articletitle","label":"Article Title"},{"value":"Reumatolog\u00eda Cl\u00ednica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.reuma.2020.07.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Espa\u00f1a, S.L.U. and Sociedad Espa\u00f1ola de Reumatolog\u00eda y Colegio Mexicano de Reumatolog\u00eda. All rights reserved.","name":"copyright","label":"Copyright"}]}}